Pershing Square Activist Presentation Deck

Highly Concentrated Portfolio Allergan's top four drugs contribute 64% of total revenue Other Products 36% Alphagan Franchise 7% Lumigan Franchise 9% Botox 32% Restasis 16% Source: Sales for top drugs per Valeant management estimates. Total AGN sales per consensus estimates as of June 19, 2014.

View entire presentation